Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
558 studies found for:    "Visceral steatosis"
Show Display Options
Rank Status Study
21 Completed
Has Results
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Condition: Non-alcoholic Steatohepatitis
Interventions: Other: Placebo;   Drug: Silymarin 700 mg;   Drug: Silymarin 420 mg
22 Completed Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet
Condition: Hepatic Steatosis
Interventions: Dietary Supplement: Ctl;   Dietary Supplement: High fructose diet; no coffee;   Dietary Supplement: fully torrefied, caffeine-free coffee;   Dietary Supplement: partially torrefied, caffeine-free coffee;   Dietary Supplement: Partially torrefied, caffeinated coffee
23 Withdrawn Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Biological: IMM 124-E;   Biological: Placebo
24 Completed Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Steatohepatitis;   Fatty Liver
Interventions: Drug: Omega 3 Fish Oil supplements;   Drug: Placebo
25 Completed Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Drug: GR-MD-02;   Drug: Placebo
26 Enrolling by invitation Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis
Condition: •Non-alcoholic Steatohepatitis (NASH)
Interventions: Drug: Ezetimibe;   Behavioral: Lifestyle
27 Enrolling by invitation Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Intervention: Drug: Colesevelam Hcl
28 Terminated
Has Results
Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis (NASH);   Hepatic Steatosis
Interventions: Drug: Omega-3-acid ethyl esters (Lovaza);   Drug: Placebo
29 Completed The Effect of Protandim on Non-alcoholic Steatohepatitis
Condition: Non-Alcoholic Steatohepatitis
Interventions: Dietary Supplement: Protandim;   Dietary Supplement: Placebo
30 Completed The Effect of Pentoxifylline on Liver Function Tests in Fatty Liver Disease
Condition: Fatty Liver
Interventions: Drug: Pentoxifylline;   Behavioral: Lifestyle modification
31 Completed Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Intervention: Drug: TRO19622
32 Recruiting Nonalcoholic Fatty Liver Disease in Taiwanese Children
Condition: Fatty Liver
Intervention:
33 Completed Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Fatty Liver Disease;   Non-alcoholic Steatohepatitis
Intervention: Other: Omega-3 capsules-Fish Oil
34 Completed
Has Results
Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)
Conditions: Non-alcoholic Fatty Liver Disease;   Nonalcoholic Steatohepatitis
Interventions: Device: Tru-cut biopsy;   Procedure: Tru-cut
35 Completed
Has Results
Pentoxifylline in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: pentoxifylline (PTX);   Drug: placebo
36 Unknown  Metformin in Non-Alcoholic Fatty Liver Disease
Condition: Fatty Liver
Intervention: Drug: metformin
37 Completed Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Dietary Supplement: Viusid;   Other: Hypocaloric Diet with controlled exercise
38 Completed
Has Results
Study to Assess the Effect of Cannabidiol on Liver Fat Levels in Subjects With Fatty Liver Disease.
Condition: Fatty Liver
Intervention: Drug: Cannabidiol
39 Completed The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease
Condition: Non Alcoholic Fatty Liver Disease
Interventions: Drug: Omacor;   Drug: lactose tablet
40 Completed A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH)
Condition: Fatty Liver
Intervention: Drug: IdB 1016 (Siliphos)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.